Equities

Kovo Healthtech Corp

KOVO:CVE

Kovo Healthtech Corp

Actions
  • Price (CAD)0.03
  • Today's Change0.00 / 0.00%
  • Shares traded99.00k
  • 1 Year change-76.00%
  • Beta--
Data delayed at least 15 minutes, as of Jul 03 2024 15:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kovo HealthTech Corporation is a Canada-based healthcare technology company. The Company is focused on providing healthcare Billing-as-a-Service. The Company sells services and software to medical clinics and medical facilities. The Company is engaged in delivering software solutions and services including Revenue Cycle Management (RCM) and Electronic Health Records (EHR) to medical practices and hospitals. The Company's services include Ambulatory services, Inpatient system services and Software service, and RCM billing services. Its RCM billing services is an outsourced service offered to clinics and hospitals for the management of the complex coding and filing required by medical practitioners to receive payment for their work from insurance companies and governmental agencies through programs. The Company offers its solutions to the industry, such as e-health, technology, medical billing, compliance, mergers and acquisitions and finance.

  • Revenue in CAD (TTM)14.68m
  • Net income in CAD-8.18m
  • Incorporated2020
  • Employees--
  • Location
    Kovo Healthtech Corp1600 - 925 West Georgia StreetVANCOUVER V6C 3L2CanadaCAN
  • Websitehttps://kovo.co/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CardioComm Solutions Inc731.38k-67.68k755.22k16.00------1.03-0.0005-0.00050.0048-0.0032.141.255.08---19.84-56.56----92.2779.38-9.25-28.730.2814-6.37-----11.99-4.01-3,856.50---34.07--
Verisante Technology Inc0.00-86.92k1.54m8.00--122.73-----0.0023-0.00230.000.00030.00-------161.65188.29-291.14--------------0.42710.00-----107.53------
Kovo Healthtech Corp14.68m-8.18m1.72m--------0.1175-0.1442-0.14420.2593-0.05791.35--50.67---75.16---262.73-------55.68-----1.781.43---5.04---1,773.60------
ZoomMed Inc154.28k1.46m2.10m------1.3613.610.01070.01070.0011-0.001415.76--46.89--14,863.23----------943.16----------3,951.93--114.30------
Binovi Technologies Corp-100.00bn-100.00bn2.25m0.00---------------0.0873-----------170.25---254.88--71.98---1,712.660.3215-------74.4213.94-79.12------
Lattice Biologics Ltd2.13m-1.30m4.16m--------1.95-0.0102-0.01020.01680.00111.013.838.70---61.69------28.53---61.08--0.00-1.020.00--12.60---46.52------
Data as of Jul 03 2024. Currency figures normalised to Kovo Healthtech Corp's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.